Mandi Cruz Media

10/13/2026

Cannabis saves lives https://www.facebook.com/share/v/1RFczpSvx6/

10/12/2026

THIS Thursday, October 15! 🌙✨
5 to 7 PM at The Ryvanta Vendor Village in Middle River, MD — free cannabis education at my table, real conversations about your medicine, and a raffle for a FREE copy of Cannabis 101: A Beginner's Field Guide 📖. Apparel pre-orders are open too.
Come ask me your questions — that's what I'm there for 💜
📍 9600 Pulaski Hwy, Middle River, MD 21220
🕔 Thursday, Oct 15 · 5–7 PM
🔞 21+

10/11/2026

10/11/2026

Your pain is real. The research finally agrees. 💜
I went deep into the peer-reviewed research on cannabis and women's health — from menstrual cramps to menopause — and here's what the numbers actually say:
🌿 Oral C*D taken across three cycles reduced menstrual pain, irritability, anxiety, and nausea — with improvements starting in month one.
📊 Endometriosis: in an Australian survey, women rated cannabis 7.6 out of 10 for pain relief, and 56% cut their pharmaceutical medications in half. A German pilot study using a daily THC:C*D oil saw pain, opioid use, and anxiety all drop together.
🧠 Migraine: in the first real placebo-controlled trial, THC plus C*D beat placebo — 67% got relief versus 47%. C*D alone did nothing. The whole plant matters.
💪 Fibromyalgia: over six months, in a study that was mostly women, median pain fell from 9 out of 10 to 5.
🌙 Menopause: one in three women report using cannabis for sleep and anxiety — and three-quarters of them say it helps.
🔬 And in the lab: cannabinoids triggered programmed cell death in breast cancer cells, and a 2026 study showed they made tumors more responsive to tamoxifen.
Here's the part that stopped me: in January 2025, Illinois added endometriosis, uterine fibroids, and ovarian cysts as qualifying conditions for medical cannabis. The research made them do it.
The data's been here. Medicine's just catching up.
This is education, not medical advice — talk to your clinician about your own care. Full study breakdown in my research library (link in comments).
Hoodie love to Bmore FourTwenty 🖤

10/08/2026

Pop-up alert! 🚀 This Saturday, October 10 — find me at Ritual Dispensary in Glen Burnie, 1:30–3:30 PM.

Stop by my table for FREE cannabis education. Ask your questions — no question too basic. And enter the raffle to win a FREE copy of Cannabis 101: A Beginner's Field Guide 📖

📍 7010 Ritchie Highway, Glen Burnie, MD
🕐 Saturday, 1:30–3:30 PM
🔞 21+

Tag someone who needs to be there — see you Saturday! 💫

mandicruzmedia.com

10/08/2026

5,162 Danish men. Intelligence tested at age 20, tested again at 64 — 44 years apart.
The men with a history of cannabis use showed less cognitive decline than the men who never used. Among users, neither starting younger nor using more often was linked to greater decline.
The researchers' own conclusion: "no significant harmful effects of cannabis use on age-related cognitive decline."
Their words — from 44 years of data on over 5,000 men.
This was men. So where's the women's study? That's the next episode. 👀
Study: Høeg et al., Brain and Behavior, 2024 — https://pubmed.ncbi.nlm.nih.gov/39508467/
Follow — the science isn't going anywhere. 🎓

10/08/2026

The DEA Said What? Zero Ma*****na Overdose Deaths Ever Reported

The DEA's own 2026 Drugs of Abuse guide states: "No deaths from overdose of ma*****na have ever been reported."
That's their word — ma*****na — I'm quoting them exactly.
In the same country, the CDC estimated 44,564 U.S. opioid-involved overdose deaths in 2025.
Zero recorded overdose deaths — and educators like me get treated like a cartel for teaching the science. Tens of thousands of opioid deaths a year — available with a prescription pad.
This isn't about saying cannabis is harmless. It's about making the policy match the evidence. The pharmacology backs it up: cannabinoid receptors aren't concentrated in the brainstem regions that control breathing. Opioid receptors are.
That's not safety. That's stigma with a terms-of-service costume.
Read the DEA coverage here:

https://www.ma*****namoment.net/there-are-no-deaths-from-overdose-of-ma*****na-dea-confirms-in-updated-report/

Follow — the science isn't going anywhere. 🎓

10/05/2026

I have a master's degree in cannabis science. I share peer-reviewed research. And the platforms treat me like a cartel.

Meanwhile, bots can spread fake medical claims about cannabis all day long — a USC study looked at 60,000+ cannabis tweets and found exactly that — while educators citing real science get throttled. Nearly 100 organizations, including NORML, the Drug Policy Alliance, and the Ma*****na Policy Project, signed an open letter demanding Meta stop censoring cannabis education.

And you can't even buy your way past it. Meta, TikTok, and Google all ban cannabis ads outright. They won't even take the money.

It's not about safety. It's stigma with a terms-of-service costume. Cannabis censorship is senseless.

Read the SSDP open letter here: https://ssdp.org/blog/organizations-around-the-world-call-on-facebook-and-instagram-parent-company-meta-to-stop-censorship-of-cannabis-psychedelic-and-harm-reduction-related-content/

10/04/2026

Living with Ehlers-Danlos syndrome means living with pain that doesn't fit in one box — joints that won't stay put, muscles working overtime, nerve pain, migraines, POTS complicating everything.

That's why I don't believe in one-size-fits-all cannabis products either. Topicals can be great for localized pain. Transdermals are built to absorb through the skin — a fundamentally different tool. Systemic products may make more sense when pain is everywhere. Different cannabinoids, different terpenes, different combinations for different symptoms. Not less, just different.

And the skill nobody teaches you: reading the COA. Once you can read the cannabinoid breakdown and terpene profile, you stop guessing and start making informed choices for the symptom you actually have.

I wrote a full walkthrough on reading COAs and labels here:

https://www.mandicruzmedia.com/pages/reading-labels-certificates-of-analysis-coas